AMY ZIMMERMAN: Open Payments
NPI 1396980330 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,254 in 50 payments from 22 companies in 2025. Trend: 2023 $262 · 2024 $827 · 2025 $1,254
Food & beverage: $1,254
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $262 |
| EMD Serono, Inc. | 7 | $198 |
| Alexion Pharmaceuticals, Inc. | 1 | $121 |
| Teva Pharmaceuticals USA, Inc. | 3 | $67 |
| Genentech USA, Inc. | 3 | $61 |
| UCB, Inc. | 3 | $61 |
| TG Therapeutics, Inc. | 2 | $57 |
| Aucta Pharmaceuticals, Inc. | 2 | $46 |
| Janssen Scientific Affairs, LLC | 1 | $44 |
| Lundbeck LLC | 2 | $42 |
Products named: UBRELVY, BOTOX, Mavenclad, VYALEV, Ocrevus Zunovo, Rystiggo, BRIUMVI, REXULTI.
Industry payments across MI — which companies pay providers there.
